Alignment Healthcare's 86.3% MBR Rides a High-Acuity SNP Bet

Alignment Healthcare's adjusted medical benefit ratio fell to 86.3% in the second quarter of 2026, the lowest since its 2021 IPO, even as half of the 31% membership growth it added came from chronic special needs plan, dual-eligible special needs plan, or full dual-eligible members.

That cohort raises near-term claims cost ahead of the risk-adjustment revenue calibrated to match it.

Key Takeaways

Half of 2026's new members entered as C-SNP, D-SNP or full dual-eligible, a structurally higher-acuity mix than the base book, on total health plan membership of 294,100, up 31% year over year.
The ratio improved 40 basis points while absorbing that drag, which is a different underlying signal than the same 40 basis points on a flat-mix book.
CMS risk scores are built from diagnoses submitted during the plan's own encounters, so a member enrolled in January is not fully paid for that member's true risk until well into the following payment year.
$556 million was the Kaiser Permanente False Claims Act settlement in January 2026, over nearly 500,000 added diagnoses. That is the same coding process the revenue catch-up runs through.

What Alignment Actually Reported

Total revenue reached $1.34 billion, up 32% year over year, while net income more than doubled to $36.6 million. Adjusted EBITDA came in at $68.1 million, a 5.1% margin and 60 basis points of year-over-year expansion, on adjusted gross profit of $183 million with adjusted SG&A held to 8.6% of revenue (Q2 2026 earnings call, July 30, 2026).

Cash and liquidity stood at $702 million, first-half operating cash flow reached $111 million, and funded leverage ran 2.2 times trailing-twelve-month EBITDA. Full-year 2026 guidance rose to $5.20 billion to $5.23 billion in revenue and $145 million to $163 million in adjusted EBITDA, both above the ranges set entering the year.

CFO Thomas Freeman was direct about the composition: "New member mix year over year, we just have more acuity in the new member mix, which is adding a little bit more to the MBR across the board." That sentence describes the ratio's composition rather than its direction, and it is the mechanism the headline number was built on top of.

Why Acuity Mix Changes the Ratio's Meaning

A medical benefit ratio blends two moving pieces a single percentage cannot separate: the medical cost a member actually incurs, and the risk-adjusted revenue CMS pays to cover that cost. For a stable, seasoned membership base, both sides move together and the ratio behaves as a clean read on care-management efficiency. A cohort of new SNP and dual-eligible members breaks that symmetry in a specific, well-understood direction.

These members typically present with more diagnosed chronic conditions, higher near-term utilization, and, for duals, wraparound Medicaid-covered costs that complicate cost attribution. All of it hits the claims side of the ratio in month one. The revenue side lags behind it. Hierarchical Condition Category risk scores for a new member are built from diagnosis codes submitted during the plan's own encounters, so a member enrolled in January is not fully risk-scored, and the plan is not fully paid for that member's true risk, until well into the following payment year.

That is why a 40-basis-point improvement here reads differently from the same move on a flat-mix book. It means the Care Anywhere clinical model and the AVA stratification tool, which the company says predicts the roughly 10% of members likely to drive nearly 70% of hospital admissions in the next 30 days, are offsetting a real and quantifiable headwind rather than coasting on an easy comparison.

The contrast with Clover Health's 87.6% benefit expense ratio on 49% membership growth, reported four weeks earlier, makes the distinction concrete. Clover's improvement traced to cohort maturation, with members who joined in 2025 producing markedly better second-year economics: a story about the passage of time inside a standard-acuity book. Alignment's improvement happened despite its 2026 cohort composition. The segment itself is not an idiosyncratic bet, either. D-SNP enrollment has nearly tripled from 2.2 million to 6.0 million members since 2018, and SNP margins run roughly double the broader Medicare Advantage average.

The Revenue Catch-Up Runs Through the Most Audited Process in the Business

The diagnosis-coding process that determines how quickly risk-adjustment revenue catches up to a high-acuity cohort is also the process under the heaviest federal scrutiny in Medicare Advantage. The Department of Justice settled with five Kaiser Permanente affiliates for $556 million on January 14, 2026, over allegations that queries prompted providers to add diagnoses months after a visit and that physician compensation was tied to risk-adjustment coding targets, practices DOJ said generated roughly $1 billion in unsupported payments across nearly 500,000 added diagnoses (Bass, Berry & Sims).

That dwarfs Cigna's $172 million in 2023 and Independent Health's $100 million in 2024, and the pattern has not slowed: $117.7 million in March 2026 and $56.5 million in June 2026 on similar allegations. Alignment has disclosed no allegation resembling that fact pattern. Its own exposure runs through the audit channel instead.

Alignment's California HMO plan was notified on June 25, 2025 that it had been selected for a CMS Risk Adjustment Data Validation audit covering payment year 2019 (Form 10-Q). A 2023 CMS final rule extrapolates audit findings to the full contract rather than only the sampled members, and does so without the fee-for-service adjuster that previously discounted findings for the error rate baked into CMS's own claims data. The same rate of unsupported diagnoses in a sample now extrapolates to a materially larger recoupment.

2027 pressure point	Mechanism	Effect on Alignment's bid
Star ratings litigation	Alignment, Elevance, SCAN separately suing CMS over unapplied Clover-style recalculation	$50M quality-bonus claim unresolved heading into the 2027 bid cycle
V28 recalibration deferral	CMS kept 2018/2019 base data rather than updating to current FFS experience	Removes one source of 2027 revenue uncertainty, but leaves the full-weight compression from 2026 in place
Audio-only and chart-review exclusions	Those diagnosis sources no longer count toward HCC risk scores starting 2027	Disproportionately affects SNP/dual outreach coding relative to standard-acuity members

An adverse finding would land as a retrospective reduction to booked risk-adjustment revenue, the opposite side of the ratio from where this quarter's acuity pressure showed up. Two changes for 2027 push the same way: diagnoses drawn from unlinked chart-review records and from audio-only encounters no longer count toward risk scores, which falls disproportionately on SNP and dual-eligible outreach, where telephonic and chart-review coding capture a larger share of documented conditions (Georgetown Center for Children and Families). Alignment's own $50 million star-ratings claim, filed July 10, 2026 after Clover Insurance Company v. HHS found 20 measures in the 2026 calculation unlawful, is still unresolved heading into the bid.

Alignment Healthcare's 86.3% MBR Rides a High-Acuity SNP Bet

Key Takeaways

What Alignment Actually Reported

Why Acuity Mix Changes the Ratio's Meaning

The Revenue Catch-Up Runs Through the Most Audited Process in the Business

Further Reading

Sources